Skip to content

Medpace Holdings, Inc. MEDP Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
IQVIA logo
IQVIAIQV
Veeva Systems logo
Veeva SystemsVEEV
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Guardant Health logo
Guardant HealthGH
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s common stock, shares, outstanding?
Medpace Holdings, Inc. (MEDP) reported common stock, shares, outstanding of $28.56M in Q1 2026.
How has Medpace Holdings, Inc.'s common stock, shares, outstanding changed year-over-year?
Medpace Holdings, Inc.'s common stock, shares, outstanding decreased by 4.3% year-over-year, from $29.84M to $28.56M.
What is the long-term trend for Medpace Holdings, Inc.'s common stock, shares, outstanding?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s common stock, shares, outstanding has grown at a -5.8% compound annual growth rate (CAGR), from $36.01M to $28.37M.